These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 36993958)

  • 1. Integrated pan-cancer analysis and experimental verification of the roles of tropomyosin 4 in gastric cancer.
    Guo Q; Zhao L; Yan N; Li Y; Guo C; Dang S; Shen X; Han J; Luo Y
    Front Immunol; 2023; 14():1148056. PubMed ID: 36993958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
    Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
    Front Immunol; 2022; 13():849592. PubMed ID: 35444654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer.
    Yuan W; Han J; Chen C; Qiu Y; Xu Y; Huang Y; Chen Z; Xu A; Sun M
    Aging (Albany NY); 2024 Aug; 16(16):12029-12049. PubMed ID: 39181686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer Analysis of the Disulfidptosis-related Gene NCKAP1 and Its Prognostic Value for Lung Adenocarcinoma.
    Zhu A; Zong Y; Wei S; Li Y; Fan Y; Liu S; Gao X
    J Cancer; 2023; 14(17):3351-3367. PubMed ID: 37928421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pan-cancer characterization of immune-related NFIL3 identifies potential predictive biomarker.
    Fei Q; Zhang X; Wang S; Shu G; Yin G
    J Cancer; 2024; 15(5):1271-1286. PubMed ID: 38356719
    [No Abstract]   [Full Text] [Related]  

  • 7. Comprehensive analysis of clinical prognosis and molecular immune characterization of tropomyosin 4 in pancreatic cancer.
    Zhou X; Zhu X; Yao J; Wang X; Wang N
    Invest New Drugs; 2021 Dec; 39(6):1469-1483. PubMed ID: 33983530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SFTA1P promotes cervical cancer progression by interaction with PTBP1 to facilitate TPM4 mRNA degradation.
    Luo A; Lan X; Qiu Q; Zhou Q; Li J; Wu M; Liu P; Zhang H; Lu B; Lu Y; Lu W
    Cell Death Dis; 2022 Nov; 13(11):936. PubMed ID: 36344495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Integrated Analysis Identified TAGLN2 As an Oncogene Indicator Related to Prognosis and Immunity in Pan-Cancer.
    Pan T; Wang S; Wang Z
    J Cancer; 2023; 14(10):1809-1836. PubMed ID: 37476180
    [No Abstract]   [Full Text] [Related]  

  • 10. A Comprehensive Analysis of the Prognostic, Immunological and Diagnostic Role of CCNF in Pan-cancer.
    Gao X; Bu H; Ge J; Gao X; Wang Y; Zhang Z; Wang L
    J Cancer; 2023; 14(13):2431-2442. PubMed ID: 37670965
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
    Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
    PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
    Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F
    J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2.
    Wu X; Chen H; You C; Peng Z
    Hereditas; 2023 May; 160(1):21. PubMed ID: 37170390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-Cancer Analysis and Experimental Validation of CEND1 as a Prognostic and Immune Infiltration-Associated Biomarker for Gliomas.
    Ma J; Lang B; Wang L; Zhou Y; Fu C; Tian C; Xue L
    Mol Biotechnol; 2024 Jun; ():. PubMed ID: 38836983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with glioma.
    Li Y; Zhang Y; Wu Z; Sun P
    BMC Neurol; 2023 Jan; 23(1):17. PubMed ID: 36639743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments.
    Zhu H; Wang G; Zhu H; Xu A
    J Cancer; 2021; 12(12):3611-3625. PubMed ID: 33995638
    [No Abstract]   [Full Text] [Related]  

  • 17. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
    Mei D; Qi Y; Xia Y; Ma J; Hu H; Ai J; Chen L; Wu N; Liao D
    World J Surg Oncol; 2021 Oct; 19(1):311. PubMed ID: 34686186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer.
    Nie K; Zheng Z; Wen Y; Pan J; Liu Y; Jiang X; Yan Y; Jiang K; Liu P; Xu S; Liu F; Li P
    Int Immunopharmacol; 2020 Oct; 87():106845. PubMed ID: 32763781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel long non-coding RNA LINC02532 promotes gastric cancer cell proliferation, migration, and invasion
    Zhang C; Ma MH; Liang Y; Wu KZ; Dai DQ
    World J Gastrointest Oncol; 2019 Feb; 11(2):91-101. PubMed ID: 30788037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEX13 is a potential immunotherapeutic indicator and prognostic biomarker for various tumors including PAAD.
    Dong P; Du X; Yang T; Li D; Du Y; Wei Y; Sun J
    Oncol Lett; 2023 Dec; 26(6):512. PubMed ID: 37920431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.